Bayer Schering Pharma Aktiengesellschaft opposition analysis

COMPANY ANALYSIS

Latest patents of Bayer Schering Pharma Aktiengesellschaft opposed by its competitors

Patent:
Grant Date:
Aug 16, 2023
Title:
Pharmaceutical Composition Containing A Tetrahydrofolic Acid
Oppositions:
1
Patent:
Grant Date:
Oct 10, 2018
Title:
Management Of Breakthrough Bleeding In Extended Hormonal Contraceptive Regimens
Oppositions:
2
Patent:
Grant Date:
Nov 8, 2017
Title:
Bolloon Catheter For Paclitaxel-Release
Oppositions:
4
Patent:
Grant Date:
Sep 6, 2017
Title:
Combination Therapy Of Substituted Oxazolidinones
Oppositions:
9

Want to track Bayer Schering Pharma Aktiengesellschaft?

Feel free to send us a message here and we will get back to you